Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Asset ManagementConsolidated Net IncomeEBITEBITDAEBTEPS (Weighted Average and Diluted)Financial Services FeesIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesInterest Income - Fed FundsInterest Income - NetInterest Income - TotalInterest Income - Trading Account AssetsInvestment Gain (Loss)Net Income - MinorityNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeNon-Interest IncomeOperating ExpensesOther Operating ExpensesProfit After TaxProvisionsRent ExpenseResearch & DevelopmentRevenueService ChargesShares Outstanding (Diluted Average)Tax ProvisionsTax RateTax RateTrading IncomeWages, Salaries and Other
Others
Ratios

Nomura Holdings (NMR) Investment Gain (Loss) (2016 - 2026)

Nomura Holdings has reported Investment Gain (Loss) over the past 18 years, most recently at $373.6 million for Q1 2026.

  • For Q1 2026, Investment Gain (Loss) rose 7.0% year-over-year to $373.6 million; the TTM value through Mar 2026 reached $1.3 billion, down 5.05%, while the annual FY2026 figure was -$83.3 million, 105.99% down from the prior year.
  • Investment Gain (Loss) for Q1 2026 was $373.6 million at Nomura Holdings, down from $383.7 million in the prior quarter.
  • Over five years, Investment Gain (Loss) peaked at $423.4 million in Q4 2024 and troughed at $175.1 million in Q3 2022.
  • A 5-year average of $296.6 million and a median of $292.4 million in 2022 define the central range for Investment Gain (Loss).
  • Biggest five-year swings in Investment Gain (Loss): plummeted 43.13% in 2022 and later surged 56.25% in 2023.
  • Year by year, Investment Gain (Loss) stood at $239.1 million in 2022, then surged by 56.25% to $373.6 million in 2023, then increased by 13.33% to $423.4 million in 2024, then dropped by 9.39% to $383.7 million in 2025, then fell by 2.62% to $373.6 million in 2026.
  • Business Quant data shows Investment Gain (Loss) for NMR at $373.6 million in Q1 2026, $383.7 million in Q4 2025, and $302.4 million in Q3 2025.